80 Biggest Movers From Yesterday

Gainers

• Synthorx, Inc. THOR shares jumped 170.5% to close at $67.71 on Monday after the company announced it would be acquired by Sanofi for $68 per share in cash.
• Forty Seven, Inc. FTSV shares rose 110.7% to close at $30.43 after the company announced data for its Magrolimab trial showing a complete response rate of 50% and an overall response rate of 92% observed in untreated patients with risk in Myelodysplastic syndrome.
• ArQule, Inc. ARQL shares gained 103.9% to close at $19.70 after the company agreed to be acquired by Merck & Co., Inc. MRK for $20 per share in cash.
• XBiotech Inc. XBIT shares gained 75.4% to close at $19.50 after the company announced it would license its anti-inflammatory antibody to Janssen for $750 million in cash and up to $600 million in milestone payments.
• Neoleukin Therapeutics, Inc. NLTX climbed 54.7% to close at $6.28.
• Fate Therapeutics, Inc. FATE shares gained 41.3% to close at $19.32 after the company announced positive preliminary data from its FT596 study and Wells Fargo upgraded its rating of the stock to Outperform.
• Aptose Biosciences Inc. APTO rose 38.3% to close at $3.54.
• LMP Automotive Holdings Inc LMPX gained 37.9% to close at $7.93.
• Hebron Technology Co., Ltd. HEBT shares rose 33.2% to close at $8.27 after announcing a $6.5 million private placement.
• TG Therapeutics, Inc. TGTX surged 30.3% to close at $9.28 after the company announced a 100% overall response rate in its phase 1/2 study of ublituximab.
• Stage Stores, Inc. SSI shares rose 25.5% to close at $7.09.
• DermTech, Inc. DMTK gained 24.1% to close at $14.77.
• PDL BioPharma Inc PDLI jumped 21.9% to close at $3.5950 after the company announced the completion of its strategic review. It will halt the execution of its growth strategy and focus on returning proceeds from asset sales to shareholders. The company also announced a $200 million buyback.
• Iterum Therapeutics plc ITRM gained 21.7% to close at $3.98.
• Alimera Sciences, Inc. ALIM rose 21% to close at $9.10.
• Repro Med Systems, Inc. KRMD shares rose 20.7% to close at $5.94.
• BioNTech SE BNTX gained 19% to close at $29.00.
• IVERIC bio, Inc. ISEE gained 18.6% to close at $5.22.
• Rekor Systems, Inc. REKR shares jumped 17.7% to close at $3.00.
• Antero Resources Corp AR gained 17.4% to close at $2.57 after Antero Midstream announced a $100 million buyback of the company's stock.
• Avadel Pharmaceuticals plc AVDL gained 16.5% to close at $7.34.
• GTY Technology Holdings Inc. GTYH rose 16.5% to close at $5.93.
• Eros International Plc EROS jumped 16.5% to close at $3.04.
• Virgin Galactic Holdings Inc SPCE climbed 16% to close at $8.42 after Morgan Stanley initiated coverage on the stock with an Overweight rating and a price target of $22 per share.
• PG&E Corporation PCG climbed 15.9% to close at $11.18 after the company announced it reached a $13.5 billion settlement to resolve individual claims from recent fires including the 2018 Camp Fire and 2017 Tubbs fire.
• IRSA Inversiones y Representaciones Sociedad Anonima IRS gained 15.7% to close at $6.43.
• Dynavax Technologies Corporation DVAX shares rose 15.6% to close at $6.59.
• Dermira, Inc. DERM gained 15.4% to close at $9.09.
• comScore, Inc. SCOR shares gained 15.1% to close at $4.87.
• OptimizeRx Corporation OPRX jumped 14.6% to close at $10.36.
• OptimizeRx said its sales pipeline has increased 79% in 2019 to $84 million.
• Antero Midstream Corporation AM shares jumped 14.5% to close at $5.14 after the company announced it will buy back $100 million shares from Antero Resources.
• Canopy Growth Corporation CGC shares rose 14.2% to close at $21.29 after the company announced David Klein as the new CEO.
• SiTime Corporation SITM gained 13.7% to close at $20.50.
• Akerna Corp. KERN shares surged 13.6% to close at $11.79.
• IGM Biosciences, Inc. IGMS shares rose 13.3% to close at $25.75.
• Intra-Cellular Therapies, Inc. ITCI jumped 13.2% to close at $11.55.
• HyreCar Inc. HYRE climbed 13.1% to close at $2.51.
• Nektar Therapeutics NKTR shares rose 13% to close at $23.11 after the company presented positive data for Abstract 2866 on Sunday, and in anticipation of the company presenting new preclinical data today at the ASH 2019 meeting.
• Cortexyme, Inc. CRTX rose 12.7% to close at $31.91.
• LiveXLive Media, Inc. LIVX gained 12.6% to close at $2.59.
• BioLineRx Ltd. BLRX jumped 12.6% to close at $2.60.
• Principia Biopharma Inc. PRNB gained 12.3% to close at $41.98.
• X4 Pharmaceuticals, Inc. XFOR shares rose 12.2% to close at $12.01. Citigroup upgraded X4 Pharmaceuticals from Neutral to Buy.
• SpringWorks Therapeutics, Inc. SWTX gained 12.2% to close at $27.50.
• Daseke, Inc. DSKE surged 12.1% to close at $3.14.
• At Home Group Inc. HOME gained 11.6% to close at $6.33 on a correction after the stock dropped roughly 44% following Q3 earnings results.
• Clovis Oncology, Inc. CLVS climbed 11.5% to close at $10.71 after Jim Cramer, on CNBC's "Mad Money," said he thinks the company is a good spec.
• Oramed Pharmaceuticals Inc. ORMP climbed 11.4% to close at $5.10.
• China Automotive Systems, Inc. CAAS gained 10.8% to close at $3.90
• LG Display Co., Ltd. LPL rose 10.4% to close at $6.88.
• EnLink Midstream, LLC ENLC gained 10.1% to close at $4.91.
• Minerva Neurosciences, Inc. NERV shares jumped 8.3% to close at $6.77.
• Advaxis, Inc. ADXS gained 6.3% to close at $0.8150.
• Turning Point Therapeutics, Inc. TPTX rose 6.1% to close at $54.33.
• TransMedics Group, Inc. TMDX shares gained 5.1% to close at $20.00.

Check out these big penny stock gainers and losers

Losers

• Precision BioSciences, Inc. DTIL tumbled 51.7% to close at $9.50 on Monday after the company reported updated interim clinical data from the ongoing Phase 1 trial of its lead investigational off-the-shelf (allogeneic) chimeric antigen receptor (CAR) T cell therapy candidate, PBCAR019.
• Biocept Inc BIOC shares dipped 50% to close at $0.27 on Monday after the company priced 24.6 million unit offering at $0.405 per unit.
• Diplomat Pharmacy, Inc. DPLO dropped 32.7% to close at $3.91 after the company received a $4 per share acquisition offer from United Health's OptumRx.
• ObsEva SA OBSV fell 29.3% to close at $3.23. Obseva, which is developing orally administered, clinical-stage compounds to treat women's reproductive health conditions, announced a positive late-stage clinical readout Monday for its investigational compound to treat heavy menstrual bleeding due to uterine fibroids.
• Sterling Bancorp, Inc. SBT dipped 22.9% to close at $7.29.
• Mustang Bio, Inc. MBIO shares declined 17.7% to close at $3.17.
• Centogene N.V. CNTG dropped 17.4% to close at $8.10.
• Constellation Pharmaceuticals, Inc. CNST fell 17.3% to close at $36.14 after the company offered updated preliminary data from MANIFEST trial with CPI-0610 in oral and poster presentations at the ASH.
• Boxwood Merger Corp. BWMC dropped 14.6% to close at $8.64.
• Kosmos Energy Ltd. KOS fell 14.1% to close at $5.19.
• Garrett Motion Inc. GTX shares declined 13.4% to close at $10.05.
• Translate Bio, Inc. TBIO dropped 13.1% to close at $8.68.
• Sangamo Therapeutics, Inc. SGMO dipped 11.6% to close at $10.31 after the company announced preliminary results from 3 patients in its Phase 1/2 study of ST-400.
• Apollo Medical Holdings, Inc. AMEH dropped 11.5% to close at $16.83.
• Liquid Media Group Ltd. YVR fell 11.1% to close at $2.16.
• Tivity Health, Inc. TVTY dropped 10.6% to close at $20.23.
• Blueprint Medicines Corporation BPMC dipped 10.3% to close at $70.37.
• InMode Ltd. INMD dropped 10% to close at $42.70 as a potential sell-off after the stock increased roughly 12% on Friday.
• Celldex Therapeutics, Inc. CLDX shares fell 9.1% to close at $2.30.
• Dycom Industries, Inc. DY fell 9% to close at $46.38.
• Brigham Minerals, Inc. MNRL shares fell 8% to close at $18.13 after the company reported an 11 million share stock offering.
• Galmed Pharmaceuticals Ltd. GLMD shares fell 7.9% to close at $5.99.
• Endologix, Inc. ELGX shares fell 6% to close at $2.22.
• Global Blood Therapeutics, Inc. GBT dipped 5.3% to close at $75.11.
• Endo International plc ENDP shares fell 5.2% to close at $4.59.